To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
Active· Referred to the House Committee on Energy and Commerce.
Introduced
Apr 30, 26
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Introduced
Apr 30, 26
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Sponsors
2
Total
2
1 primary + cosponsors
Original
1
joined within 1 day of intro
Active
1
not withdrawn
Withdrawn
0
none
Bipartisan Support
Single-party
Democrat
00.0%
RepublicanPrimary
2100.0%
Independent
00.0%
Other / Unknown
00.0%
Cosponsorship Momentum
1 cosponsors over 6d
Hover the chart to scrub through time.
Geographic Distribution
2 states
Color indicates the dominant party of sponsors in each state. Hover a state for member names. Hex-grid approximation, not to scale.